| P50 | author | Coenraad Dirk Adriaan Stehouwer | Q68596151 |
| | Martijn C G J Brouwers | Q90468688 |
| | Marleen M J van Greevenbroek | Q90468691 |
| P2093 | author name string | Douwe de Boer | |
| | Jacqueline de Graaf | |
| | Nynke Simons | |
| | Jim Luijten | |
| | Nicolaas Schaper | |
| | Britt Heidemann | |
| | Shadana van Heertum | |
| | Sophie Ten Doeschate | |
| | Steven Meex | |
| P2860 | cites work | Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples | Q24642868 |
| | Correct homeostasis model assessment (HOMA) evaluation uses the computer program | Q28290512 |
| | The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population | Q33262505 |
| | 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres | Q34046881 |
| | Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. | Q51482525 |
| | Heritability and genetic loci of fatty liver in familial combined hyperlipidemia. | Q51786382 |
| | Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue | Q57388774 |
| | A proposal to redefine familial combined hyperlipidaemia - Third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the Scientific Sessions of the European Society for Clinical Investigation | Q61560239 |
| | Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM | Q73250750 |
| | Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids | Q80226605 |
| | Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg cohort study | Q80229821 |
| | Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia | Q80468924 |
| | Incidence of cardiovascular disease in familial combined hyperlipidemia: A 15-year follow-up study | Q93194597 |
| | Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial | Q34293369 |
| | Splanchnic lipolysis in human obesity | Q34328357 |
| | Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia | Q34506656 |
| | The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population | Q34656510 |
| | Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects | Q37068823 |
| | Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus | Q37782537 |
| | The genetics of familial combined hyperlipidaemia | Q37983699 |
| | Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia | Q43084847 |
| | Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity | Q43687653 |
| | Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians | Q43850960 |
| | The utility of radiological imaging in nonalcoholic fatty liver disease. | Q44116674 |
| | The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. | Q44318975 |
| | Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. | Q45030364 |
| | Role of insulin resistance in familial combined hyperlipidemia | Q45282767 |
| | Increased arterial stiffness in familial combined hyperlipidemia. | Q46032468 |
| | Overproduction of large VLDL particles is driven by increased liver fat content in man. | Q46931621 |
| | Statin Therapy and Risk of Diabetes Mellitus in Aging Patients With Heterozygous Familial Hypercholesterolemia or Familial Combined Hyperlipidemia: A 10-Year Follow-Up. | Q48168322 |
| | Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis. | Q48191216 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | familial combined hyperlipidemia | Q2242370 |
| | type 2 diabetes | Q3025883 |
| P577 | publication date | 2020-03-01 | |
| P1433 | published in | BMJ open diabetes research & care | Q27725999 |
| P1476 | title | Incidence of type 2 diabetes in familial combined hyperlipidemia | |
| P478 | volume | 8 | |